Abstract
The 621+3 A>G variant of the CFTR gene was initially detected in four Greek patients with a severe form of cystic fibrosis, and it is reported to impair CFTR mRNA splicing. We present three lines of evidence that argue against the pathogenicity of this variant. First, its allelic frequency in the Italian population was 0.4%. Even considering the lowest value in the confidence interval we would expect 10% of Italian CF patients to be heterozygotes for this variant, whereas it has been reported only in one patient (0.04% of Italian CF patients). Second, expression of the 621+3 A>G variant in HeLa cells using a hybrid minigene showed that 39.5±1.1% of transcripts were correctly spliced, indicating that its effects on mRNA splicing are similar to those of the CFTR intron 8 5T variant, associated with congenital bilateral absence of vas deferens (CBAVD), but not with CF. Third, we have identified an asymptomatic individual who harbored the 621+3 A>G variant in trans with the Q552X mutation. Because 621+3 A>G is often included in population-screening programs, this information is critical to provide adequate counseling to patients. Further work should be aimed at investigating whether this variant may have a role in CBAVD or atypical CF.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Davies, J. C., Alton, E. W. & Bush, A. Cystic fibrosis. BMJ 335, 1255–1259 (2007).
Tomaiuolo, R., Spina, M. & Castaldo, G. Molecular diagnosis of cystic fibrosis: comparison of four analytical procedures. Clin Chem Lab Med 41, 26–32 (2003).
Claustres, M., Altieri, J. P., Guittard, C., Templin, C., Chevalier-Porst, F. & Des Georges, M. Are p.I148T, p.R74W and p.D1270N cystic fibrosis causing mutations? BMC Med Genet 5, 19 (2004).
Tzetis, M., Efthymiadou, A., Doudounakis, S. & Kanavakis, E. Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A–>G, 2751+2T–>A, 296+1G–>C, 1717-9T–>C-D565G) and one nonsense mutation (E822X) in the CFTR gene. Hum Genet 109, 592–601 (2001).
Hardy, G. H. Mendelian Proportions in a Mixed Population. Science 28, 49–50 (1908).
Newcombe, R. G. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17, 857–872 (1998).
Trevisson, E., Salviati, L., Baldoin, M. C., Toldo, I., Casarin, A., Sacconi, S. et al. Argininosuccinate lyase deficiency: mutational spectrum in Italian patients and identification of a novel ASL pseudogene. Hum Mutat 28, 694–702 (2007).
Salviati, L., Trevisson, E., Baldoin, M. C., Toldo, I., Sartori, S., Calderone, M. et al. A novel deletion in the GJA12 gene causes Pelizaeus-Merzbacher-like disease. Neurogenetics 8, 57–60 (2007).
Sacconi, S., Salviati, L., Nishigaki, Y., Walker, W. F., Hernandez-Rosa, E., Trevisson, E. et al. A functionally dominant mitochondrial DNA mutation. Hum Mol Genet 17, 1814–1820 (2008).
Zielenski, J., Bozon, D., Markiewicz, D., Aubin, G., Simard, F., Rommens, J. M. et al. Analysis of CFTR transcripts in nasal epithelial cells and lymphoblasts of a cystic fibrosis patient with 621+1G–>T and 711+1G–>T mutations. Hum Mol Genet 2, 683–687 (1993).
Chillon, M., Casals, T., Gimenez, J., Ramos, M. D., Palacio, A., Morral, N. et al. Analysis of the CFTR gene confirms the high genetic heterogeneity of the Spanish population: 43 mutations account for only 78% of CF chromosomes. Hum Genet 93, 447–451 (1994).
Cartegni, L., Chew, S. L. & Krainer, A. R. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3, 285–298 (2002).
Mak, V., Jarvi, K. A., Zielenski, J., Durie, P. & Tsui, L. C. Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens. Hum Mol Genet 6, 2099–2107 (1997).
Rave-Harel, N., Kerem, E., Nissim-Rafinia, M., Madjar, I., Goshen, R., Augarten, A. et al. The molecular basis of partial penetrance of splicing mutations in cystic fibrosis. Am J Hum Genet 60, 87–94 (1997).
Martella, M., Salviati, L., Casarin, A., Trevisson, E., Opocher, G., Polli, R. et al. Molecular analysis of two uncharacterized sequence variants of the VHL gene. J Hum Genet 51, 964–968 (2006).
Zuccato, E., Buratti, E., Stuani, C., Baralle, F. E. & Pagani, F. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing. J Biol Chem 279, 16980–16988 (2004).
Pagani, F., Stuani, C., Zuccato, E., Kornblihtt, A. R. & Baralle, F. E. Promoter architecture modulates CFTR exon 9 skipping. J Biol Chem 278, 1511–1517 (2003).
Hefferon, T. W., Groman, J. D., Yurk, C. E. & Cutting, G. R. A variable dinucleotide repeat in the CFTR gene contributes to phenotype diversity by forming RNA secondary structures that alter splicing. Proc Natl Acad Sci USA 101, 3504–3509 (2004).
Loumi, O., Ferec, C., Mercier, B., Creff, J., Fercot, B., Denine, R. et al. CFTR mutations in the Algerian population. J Cyst Fibros 7, 54–59 (2008).
Hantash, F. M., Redman, J. B., Starn, K., Anderson, B., Buller, A. & McGinniss, M. J. et al. Novel and recurrent rearrangements in the CFTR gene: clinical and laboratory implications for cystic fibrosis screening. Hum Genet 119, 126–136 (2006).
Monaghan, K. G., Highsmith, W. E., Amos, J., Pratt, V. M., Roa, B., Friez, M. et al. Genotype-phenotype correlation and frequency of the 3199del6 cystic fibrosis mutation among I148T carriers: results from a collaborative study. Genet Med 6, 421–425 (2004).
Morea, A., Cameran, M., Rebuffi, A. G., Marzenta, D., Marangon, O., Picci, L. et al. Gender-sensitive association of CFTR gene mutations and 5T allele emerging from a large survey on infertility. Mol Hum Reprod 11, 607–614 (2005).
Acknowledgements
Dr Salviati is supported by a grant from AFM and by Telethon Italia Grant GGP06256.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Forzan, M., Salviati, L., Pertegato, V. et al. Is CFTR 621+3 A>G a cystic fibrosis causing mutation?. J Hum Genet 55, 23–26 (2010). https://doi.org/10.1038/jhg.2009.115
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/jhg.2009.115
Keywords
This article is cited by
-
Demographic characteristics, clinical and laboratory features, and the distribution of pathogenic variants in the CFTR gene in the Cypriot cystic fibrosis (CF) population demonstrate the utility of a national CF patient registry
Orphanet Journal of Rare Diseases (2021)
-
Parent-of-origin effect of hypomorphic pathogenic variants and somatic mosaicism impact on phenotypic expression of retinoblastoma
European Journal of Human Genetics (2018)
-
A synonymous splicing mutation in the SF3B4 gene segregates in a family with highly variable Nager syndrome
European Journal of Human Genetics (2017)
